These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22815080)

  • 21. Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.
    Yip AG; Brayne C; Easton D; Rubinsztein DC;
    J Med Genet; 2002 Sep; 39(9):639-43. PubMed ID: 12205106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study.
    Gharbi-Meliani A; Dugravot A; Sabia S; Regy M; Fayosse A; Schnitzler A; Kivimäki M; Singh-Manoux A; Dumurgier J
    Alzheimers Res Ther; 2021 Jan; 13(1):5. PubMed ID: 33397450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
    Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
    Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
    Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
    BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOE ε4 increases the risk of progression from amnestic mild cognitive impairment to Alzheimer's disease among ethnic Chinese in Taiwan.
    Wang PN; Hong CJ; Lin KN; Liu HC; Chen WT
    J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):165-9. PubMed ID: 20660919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E epsilon4 allele frequency and age at onset of Alzheimer's disease.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Stopford C; Julien C; Thompson J; Payton A; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    Dement Geriatr Cogn Disord; 2007; 23(1):60-6. PubMed ID: 17108687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
    Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA
    Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
    Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
    Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
    Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
    PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
    Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
    Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study.
    Hayden KM; Zandi PP; West NA; Tschanz JT; Norton MC; Corcoran C; Breitner JC; Welsh-Bohmer KA;
    Arch Neurol; 2009 Nov; 66(11):1378-83. PubMed ID: 19901170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of Apolipoprotein E Polymorphisms in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: A Northern Greece Study.
    Tsolaki AC; Gatzima O; Daniilidou M; Lazarou E; Bamidis PD; Verykouki E; Iakovidou-Kritsi Z; Tsolaki M
    Neurodegener Dis; 2018; 18(4):216-224. PubMed ID: 30205398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of apolipoproteins e4 and c1 with onset age and memory: a study of sporadic Alzheimer disease in Taiwan.
    Chuang WL; Hsieh YC; Wang CY; Kuo HC; Huang CC
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):42-8. PubMed ID: 20145290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
    Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
    Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis.
    Chen Q; Wang T; Kang D; Chen L
    Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOE epsilon4 and Alzheimer's disease: positive association in a Colombian clinical series and review of the Latin-American studies.
    Jacquier M; Arango D; Villareal E; Torres O; Serrano ML; Cruts M; Montañes P; Cano C; Rodriguez MN; Serneels S; Van Broeckhoven C
    Arq Neuropsiquiatr; 2001 Mar; 59(1):11-7. PubMed ID: 11299424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.
    Mayeux R; Saunders AM; Shea S; Mirra S; Evans D; Roses AD; Hyman BT; Crain B; Tang MX; Phelps CH
    N Engl J Med; 1998 Feb; 338(8):506-11. PubMed ID: 9468467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.